Maersk-Andersen has entered into an agreement to distribute Misonix's ultrasonic bone cutting device throughout Denmark.
The device, BoneScalpel Ultrasonic Bone Cutting System, is used for safe, tissue-selective bone dissection that encourages non-fragmented bone removal and refined osteotomies while sparing elastic soft tissue structures.
The device, in general, has been used for bone removal in spine surgery and maxillo-facial reconstructive surgery, according to Misonix.
Annual minimum purchase requirements are also included in the three year agreement.
Misonix president and chief executive officer Michael McManus said, "It is our pleasure to add Maersk-Andersen to our distribution organization in Europe; their presence in a sophisticated healthcare market like Denmark could add measurably to our sales success."
Misonix's proprietary ultrasonic medical devices are also used for wound debridement, cosmetic surgery, neurosurgery, laparoscopic surgery, and other surgical and medical applications.
